Randomised double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure

Anne Keogh; Steve Fenton; Christina Leslie; Christina Aboyoun; Peter Macdonald;  Yi Chen Zhao; Michael Bailey; Franklin Rosenfeldt

doi:10.1046/j.1443-9506.2003.00189.x

Randomised double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure

Heart Lung and Circulation ◽

10.1046/j.1443-9506.2003.00189.x ◽

2003 ◽

Vol 12 (3) ◽

pp. 135-141 ◽

Cited By ~ 35

Author(s):

Anne Keogh ◽

Steve Fenton ◽

Christina Leslie ◽

Christina Aboyoun ◽

Peter Macdonald ◽

...

Keyword(s):

Heart Failure ◽

Coenzyme Q10 ◽

Controlled Trial ◽

Systolic Heart Failure ◽

Class Ii ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Drugs in R&D ◽

10.1007/s40268-021-00372-1 ◽

2021 ◽

Author(s):

Tal Y. Samuel ◽

Tal Hasin ◽

Israel Gotsman ◽

Tanya Weitzman ◽

Fanny Ben Ivgi ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Coenzyme Q10 ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

PDE 5 Inhibition With Udenafil Improves Left Ventricular Systolic/Diastolic Function and Exercise Capacity in Patients With Chronic Systolic Heart Failure: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial (Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure) (ULTIMATE-SHF)

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2015.01.422 ◽

2015 ◽

Vol 34 (4) ◽

pp. S156

Author(s):

K. Kim ◽

H. Kim ◽

D. Lim

Keyword(s):

Heart Failure ◽

Diastolic Function ◽

Exercise Capacity ◽

Exercise Tolerance ◽

Controlled Trial ◽

Systolic Heart Failure ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Chronic Systolic Heart Failure

Download Full-text

Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens

International Journal of Cardiology ◽

10.1016/j.ijcard.2012.04.156 ◽

2013 ◽

Vol 167 (5) ◽

pp. 1860-1866 ◽

Cited By ~ 63

Author(s):

Urban Alehagen ◽

Peter Johansson ◽

Mikael Björnstedt ◽

Anders Rosén ◽

Ulf Dahlström

Keyword(s):

Cardiovascular Mortality ◽

Coenzyme Q10 ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Coenzyme Q10 Supplementation

Download Full-text

The Effects of METhotrexate Therapy on the Physical Capacity of Patients With ISchemic Heart Failure: A Randomized Double-Blind, Placebo-Controlled Trial (METIS Trial)

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2009.06.439 ◽

2009 ◽

Vol 15 (10) ◽

pp. 828-834 ◽

Cited By ~ 24

Author(s):

Daniel Medeiros Moreira ◽

Jefferson Luís Vieira ◽

Carlos Antônio Mascia Gottschall

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Physical Capacity ◽

Ischemic Heart ◽

Ischemic Heart Failure ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

The Lancet ◽

10.1016/s0140-6736(11)61126-4 ◽

2011 ◽

Vol 378 (9792) ◽

pp. 676-683 ◽

Cited By ~ 216

Author(s):

John GF Cleland ◽

John R Teerlink ◽

Roxy Senior ◽

Evgeny M Nifontov ◽

John JV Mc Murray ◽

...

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Systolic Heart Failure ◽

Phase 2 ◽

Cardiac Myosin ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Omecamtiv Mecarbil ◽

Dose Ranging

Download Full-text

Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled Trial

Yearbook of Cardiology ◽

10.1016/j.ycar.2011.01.004 ◽

2011 ◽

Vol 2011 ◽

pp. 318-321

Author(s):

M.D. Cheitlin

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Controlled Trial ◽

Angiotensin Converting Enzyme Inhibitors ◽

Hemodialysis Patients ◽

Converting Enzyme ◽

Double Blind ◽

Converting Enzyme Inhibitors ◽

Mortality And Morbidity ◽

Double Blind Placebo

Download Full-text

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Download Full-text

Supplemental selenium and coenzyme Q10 reduce glycation along with cardiovascular mortality in an elderly population with low selenium status – A four-year, prospective, randomised, double-blind placebo-controlled trial

Journal of Trace Elements in Medicine and Biology ◽

10.1016/j.jtemb.2020.126541 ◽

2020 ◽

Vol 61 ◽

pp. 126541

Author(s):

Urban Alehagen ◽

Jan Aaseth ◽

Jan Alexander ◽

Peter Johansson ◽

Anders Larsson

Keyword(s):

Cardiovascular Mortality ◽

Coenzyme Q10 ◽

Elderly Population ◽

Controlled Trial ◽

Selenium Status ◽

Double Blind ◽

Double Blind Placebo ◽

Low Selenium

Download Full-text

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

European Journal of Heart Failure ◽

10.1002/ejhf.1656 ◽

2019 ◽

Vol 22 (9) ◽

pp. 1628-1637 ◽

Cited By ~ 8

Author(s):

Anders Hostrup Larsen ◽

Niels Jessen ◽

Helene Nørrelund ◽

Lars Poulsen Tolbod ◽

Hendrik Johannes Harms ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Insulin Resistant ◽

Myocardial Efficiency

Download Full-text

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)

American Heart Journal ◽

10.1016/j.ahj.2020.09.020 ◽

2021 ◽

Vol 231 ◽

pp. 137-146

Author(s):

Henrik Wiggers ◽

Lars Køber ◽

Gunnar Gislason ◽

Morten Schou ◽

Mikael Kjær Poulsen ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Isosorbide Dinitrate ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Factorial Trial

Download Full-text